What is IQVIA's market cap?

IQVIA (IQV) has a market capitalization of $34.0B and trades on NYSE.

What is IQVIA's revenue and profitability?

IQVIA generated $16.6B in trailing twelve-month revenue with net income of $1.4B, representing a net margin of 8.3%. Gross margin stands at 33.0%, with free cash flow of $2.1B. These figures are based on the Q1 2026 filing.

Who are IQVIA's competitors?

IQVIA's key competitors include Veeva Systems, Cognizant Technology Solutions, Accenture, and others. These companies compete in similar markets and product categories.

Who does IQVIA partner with?

IQVIA's notable partners include Hinge Health.

What subsidiaries does IQVIA have?

IQVIA's subsidiaries include Avacare Clinical Research Network.

Where is IQVIA headquartered?

IQVIA is headquartered in United States of America and employs approximately 88,000 people. It has been publicly traded since 2013.

IQVIA

IQV

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries.

Market cap

$34.01B+19.7%

Revenue$16.6B+7.3%

Net income$1.4B+3.8%

Free cash flow$2.1B-2.2%

EPS (diluted)$8.06+10.0%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 5, 2026

Revenue$4.2BBeat by $51.0M EPS$2.90Beat by $0.07

Read the full report

Next report

Jul 28, 2026 (In 2 weeks)

Revenue estimate$4.3B

EPS estimate$3.03

Financials

Q1 2026

Income statement

See full

Revenue$4.2B+8.4%

Gross profit$1.4B+4.4%

Operating income$514.0M+3.6%

Net income$274.0M+10.0%

EPS (diluted)$1.61+15.0%

Balance sheet

See full

Cash & equivalents$1.9B+11.9%

Total debt$16.1B+10.7%

Total equity$6.2B+4.1%

Total assets$29.7B+8.6%

Cash flow

See full

Operating cash flow$618.0M+8.8%

CapEx$127.0M-10.6%

Free cash flow$491.0M+15.3%

Valuation & ratios

Valuation

See full

Market cap$34.01B+19.7%

Enterprise value$48.13B+14.4%

P/E24.6×+1.6×

P/S2.1×+0.2×

Profitability

See full

Gross margin33%-1.7pp

Operating margin13.2%-0.9pp

Net margin8.3%-0.3pp

FCF margin12.7%-1.2pp

Returns & leverage

See full

Return on equity22.7%+1.1pp

Debt / equity2.6×+0.2×

Current ratio0.7×-0.1×

Segments

By geography

See full

Americas$2.0B+9.8%

Europe and Africa$1.4B+10.7%

Asia-Pacific$812.0M+1.8%

By segment

See full

Research & Development Solutions$2.4B+6.2%

Commercial Solutions$1.8B—

Competitors

By market cap

Oracle$404.68B-39.3%

UnitedHealth Group$386.51B+38.1%

Thermo Fisher Scientific$189.58B+17.0%

Accenture$84.0B-55.8%

IQVIA$34.0B+19.7%

Veeva Systems$30.6B-34.2%

Cognizant$20.1B-49.7%

Icon$12.7B+6.2%

By revenue growth

Oracle+17.3%

Veeva Systems+16.3%

UnitedHealth Group+9.7%

IQVIA+7.3%

Accenture+6.7%

Cognizant+6.6%

Thermo Fisher Scientific+2.4%

By net margin

Veeva Systems28.37%+1.0pp

Oracle25.3%+3.7pp

Thermo Fisher Scientific15.19%+0.4pp

Accenture10.66%-0.9pp

Cognizant10.41%-1.3pp

IQVIA8.33%-0.3pp

UnitedHealth Group2.68%-2.7pp

Profile

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries. The company leverages its proprietary IQVIA Connected Intelligence platform and one of the world's largest collections of healthcare data to accelerate drug development and commercialization. Its core value proposition lies in integrating high-quality health data with specialized AI and domain expertise to improve patient outcomes and operational efficiency for healthcare stakeholders.

Competitive position

A global leader in healthcare intelligence and clinical research, distinguished by a massive proprietary longitudinal patient data set and integrated AI-powered technology platforms.

GeographiesGlobal, North America, Asia, Europe, Emerging Markets

Customer segmentsBiopharmaceutical Companies, Government Agencies, Healthcare Providers, Payers

Business modelSubscription SaaS, Professional Services, Data-as-a-Service, Outsourcing

SuppliersData suppliers, Cloud infrastructure providers, Laboratory equipment manufacturers, Software developers

CustomersTop 100 global pharmaceutical companies, Biotechnology startups, Public health organizations, Medical device manufacturers, Health systems and providers

CountryUnited States of America

Listed2013

Employees88.0K

CEOAri Bousbib

SectorHealthcare

IndustryMedical - Diagnostics & Research

Websiteiqvia.com

FilingsSEC EDGAR

Ask your AI about IQVIA.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IQVIA's market cap?: IQVIA (IQV) has a market capitalization of $34.0B and trades on NYSE.
What is IQVIA's revenue and profitability?: IQVIA generated $16.6B in trailing twelve-month revenue with net income of $1.4B, representing a net margin of 8.3%. Gross margin stands at 33.0%, with free cash flow of $2.1B. These figures are based on the Q1 2026 filing.
Who are IQVIA's competitors?: IQVIA's key competitors include Veeva Systems, Cognizant Technology Solutions, Accenture, and others. These companies compete in similar markets and product categories.
Who does IQVIA partner with?: IQVIA's notable partners include Hinge Health.
What subsidiaries does IQVIA have?: IQVIA's subsidiaries include Avacare Clinical Research Network.
Where is IQVIA headquartered?: IQVIA is headquartered in United States of America and employs approximately 88,000 people. It has been publicly traded since 2013.